University of Oxford
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Oxford sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
University of Oxford: 5 sponsored US clinical trials, 1 recruiting.
University of Oxford sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Steatosis of Liver, with 1 trials.
Upper-quartile sponsor footprint
University of Oxford sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The Oxford Risk Factors And Non-Invasive Imaging Study
NCT05169333
LITMUS Imaging Study
NCT05479721
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
NCT03705234
Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients
NCT00883402
A Short CONSORT Checklist for Peer Reviewers to Improve the Reporting of Randomised Controlled Trials Published
NCT05820971
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Where University of Oxford enrollment is open (later-stage tilt)
1 recruiting of 5 indexed (20% open); 1 completed (20%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Steatosis of Liver (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Oxford: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Oxford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this University of Oxford page
5 registered trials is a research-attention snapshot, not an endorsement of University of Oxford or any single study.
- 1 of University of Oxford's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Steatosis of Liver is the condition University of Oxford studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Steatosis of Liver trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Oxford pipeline card: 5 registered trials from official public datasets.Report a data error.